ARCHIVES

Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million.

This article is from The Cancer Letter archive.

Vol. 30 No. 31 | July 30, 2004

Download PDF Visit The Full Archive

Related Articles

Changes In Clinical Trials Mechanism Inevitable, But NCI Says It will Heed Critics Of Proposals

April 18, 1986

AICR Increasing Funds for Research, Education, Supports Successful Symposium

November 7, 1986

ODAC Unanimously Rejects Melblez, Citing Lower Survival

May 17, 2013

Complete List of Recommendations by Centers Committee

October 18, 1996

New SEER RFP Sees cheaper Way To Get Data

July 29, 1977

Mack, to Retire, Calls Budget Proposal an “Act of Retreat”

March 19, 1999